Understanding and managing your outsourcing relationships within an increased globalised and regulated world.October 18th-19th 2017, Toronto, Canada
OCT Canada returns for its 7th year in Toronto, the heart of the pharmaceutical hub, after great success of the previous event.
The Arena OCT global series continues to attract a great collection of industry professionals from the pharmaceutical, medical device and biotech industry who all come with the intention of maximising the value and efficiency of their outsourcing strategies, by sharing experiences and strengthening their networks.
As always we have a fantastic variety of service providers who exhibit at the event and offer new technology and solutions to further improve your company’s existing processes.
We look forward to welcoming you to the event in October which promises to be the biggest and most dynamic we have showcased.
There is a much needed patient centric lens which will be woven throughout this year’s programme as patient needs; recruitment and retention continue to be a major challenge for professionals. A nuanced approach will be used explore this constant challenge with experiences from health regulators, pharmaceutical/biotech companies but also the much needed patients voice. Thepanel session, A Patient- Centric Lens Into The Challenges Of Patient Recruitment will allow for ...
Regulatory changes are a frequent occurrence within the industry and this is also greatly impacted by the political climate at the time. The Canadian market is affected by the proximity of the United States, and with the uncertain political climate in the States, what impact that will have on the Canadian industry. There is a concerted focus on the impact of regulatory changes on the clinical trial environment in Canada specifically. What does the future of Canada look like within this ...
For OCT we are always looking for the most senior representatives to take part, the event works based on the fact we bring decision makers, therefore always ask who the decision maker is.
The two day conference kicked off with the keynote presentation from Christopher Gallen, CEO from WEX Pharmaceuticals who gave a brilliant presentation focusing on design development plans and protocols for clinical trials. Integrating timelines, supply considerations and trial conduct approaches on global programs and being strategic in how you choose your vendors were discussed. Dr. Gallen then went on to chair the morning of day one.
Fantastic, very informative keynote speakers and engaging panel discussionAccuro Technologies